Aeterna Zentaris Provides Corporate Update

– Recently secured funding bolsters cash runway to fund operations and provides significant optionality for growth- Pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence in Q1 2021-Ongoing evaluations to expand...